Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ye Han

Showing results (471-480 of 490) with videos related to

Pageof 49
Sort By:
Zhongguo Shi Yan Xue Ye Xue Za Zhi|July 4, 2014
[Clinical study of unrelated umbilical cord blood transplantation for 25 patients with hematological diseases]Hui-Rong Chang, Zhen Cheng, Guang-Hua Chen, et al.
The Journal of Clinical Investigation|October 16, 2025
Excessive collagen type VII mediates pleural fibrosis via increasing extracellular matrix stiffnessQian Li, Xin-Liang He, Shuai-Jun Chen, et al.
Cell Communication and Signaling : CCS|February 21, 2023
BMAL1/p53 mediating bronchial epithelial cell autophagy contributes to PM2.5-aggravated asthmaShuai-Jun Chen, Yi Huang, Fan Yu, et al.
Journal of Cellular Physiology|February 11, 2020
Oncogene PLCE1 may be a diagnostic biomarker and prognostic biomarker by influencing cell cycle, proliferation, migration, and invasion ability in hepatocellular carcinoma cell linesXiang-Kun Wang, Xi-Wen Liao, Cheng-Kun Yang, et al.
The Lancet Regional Health. Western Pacific|October 13, 2025
Neoadjuvant chidamide combined with chemotherapy in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (MUKDEN 05): a multicentre, single-arm, phase 2 trialJinqi Xue, Huilian Shan, Fang Qiu, et al.
Journal of Cancer|May 17, 2021
<i>SOX4</i> as biomarker in hepatitis B virus-associated hepatocellular carcinomaJian-Lv Huang, Xiang-Kun Wang, Xi-Wen Liao, et al.
Environment International|March 6, 2025
Midkine, a novel MCP-1 activator mediated PM2.5-aggravated experimental pulmonary fibrosisPei-Pei Cheng, Xin-Liang He, Zi-Heng Jia, et al.
American Journal of Cancer Research|March 21, 2020
Blocking c-Met and EGFR reverses acquired resistance of PARP inhibitors in triple-negative breast cancerYu-Yi Chu, Clinton Yam, Mei-Kuang Chen, et al.
Viruses|May 25, 2024
Evolution Characterization and Pathogenicity of an NADC34-like PRRSV Isolated from Inner Mongolia, ChinaHong-Zhe Zhao, Chun-Yu Liu, Hai Meng, et al.
Journal of Cancer|January 18, 2020
Comprehensive investigation of p53, p21, nm23, and VEGF expression in hepatitis B virus-related hepatocellular carcinoma overall survival after hepatectomyGuang-Zhi Zhu, Xi-Wen Liao, Xiang-Kun Wang, et al.
Pageof 49

Showing results (471-480 of 490) with videos related to

Sort By:
Pageof 49
Zhongguo Shi Yan Xue Ye Xue Za Zhi|July 4, 2014
[Clinical study of unrelated umbilical cord blood transplantation for 25 patients with hematological diseases]Hui-Rong Chang, Zhen Cheng, Guang-Hua Chen, et al.
The Journal of Clinical Investigation|October 16, 2025
Excessive collagen type VII mediates pleural fibrosis via increasing extracellular matrix stiffnessQian Li, Xin-Liang He, Shuai-Jun Chen, et al.
Cell Communication and Signaling : CCS|February 21, 2023
BMAL1/p53 mediating bronchial epithelial cell autophagy contributes to PM2.5-aggravated asthmaShuai-Jun Chen, Yi Huang, Fan Yu, et al.
Journal of Cellular Physiology|February 11, 2020
Oncogene PLCE1 may be a diagnostic biomarker and prognostic biomarker by influencing cell cycle, proliferation, migration, and invasion ability in hepatocellular carcinoma cell linesXiang-Kun Wang, Xi-Wen Liao, Cheng-Kun Yang, et al.
The Lancet Regional Health. Western Pacific|October 13, 2025
Neoadjuvant chidamide combined with chemotherapy in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (MUKDEN 05): a multicentre, single-arm, phase 2 trialJinqi Xue, Huilian Shan, Fang Qiu, et al.
Journal of Cancer|May 17, 2021
<i>SOX4</i> as biomarker in hepatitis B virus-associated hepatocellular carcinomaJian-Lv Huang, Xiang-Kun Wang, Xi-Wen Liao, et al.
Environment International|March 6, 2025
Midkine, a novel MCP-1 activator mediated PM2.5-aggravated experimental pulmonary fibrosisPei-Pei Cheng, Xin-Liang He, Zi-Heng Jia, et al.
American Journal of Cancer Research|March 21, 2020
Blocking c-Met and EGFR reverses acquired resistance of PARP inhibitors in triple-negative breast cancerYu-Yi Chu, Clinton Yam, Mei-Kuang Chen, et al.
Viruses|May 25, 2024
Evolution Characterization and Pathogenicity of an NADC34-like PRRSV Isolated from Inner Mongolia, ChinaHong-Zhe Zhao, Chun-Yu Liu, Hai Meng, et al.
Journal of Cancer|January 18, 2020
Comprehensive investigation of p53, p21, nm23, and VEGF expression in hepatitis B virus-related hepatocellular carcinoma overall survival after hepatectomyGuang-Zhi Zhu, Xi-Wen Liao, Xiang-Kun Wang, et al.
Pageof 49